Get the Weekly Intelligence Brief — top committee picks every Sunday.
DHR · NYSE · STOCK

Danaher (DHR) Stock Analysis

Healthcare Updated August 25, 2026
$214.21
52W $160.93 – $242.80
60/100
$151.28B
38.1
0.80
AI Committee Verdict
Buy
60/100
Conviction: Moderate · 60% agreement · 5 analysts
+9.2%
-0.4%
21.40:1
Moderate

Is DHR Bullish or Bearish?

Bullish. Innellis AI committee rates Danaher Corporation (DHR) Buy with a composite score of 60/100 , based on 5 analysts with 60% agreement. Last updated August 25, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +15.45 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -4.55 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee sees neither a compelling opportunity nor a clear risk at this stage. Conditions remain neutral — patience is warranted.

Bull & Bear Case

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
  • News sentiment is positive (+0.20 across 16 articles, 14d) — News
Bear Case
  • P/E of 35.9 is moderate-to-rich — Value
  • RSI at 76 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 25, 2026
Overall Committee Score
60/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 41%
of 192 Healthcare peers
Value Analyst neutral
55 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 35.9 is moderate-to-rich
Growth Analyst bullish
60 / 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst neutral
54 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− RSI at 76 is in overbought territory
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
64 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 16 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3063.01)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 59.5 to 59.5.

Comparing 2026-08-24 to 2026-08-25 (1 day apart).

Technical Analysis

RSI (14)
65.8
Neutral
MACD Histogram
1.222
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Mixed
Support
$214.24
Resistance
$234.96
Bollinger %B
0.89
Inside Bands
Price vs Moving Averages
EMA 9
$210.22 Above
EMA 21
$204.86 Above
EMA 50
$198.04 Above
EMA 200
$198.65 Above

Fundamental Analysis

Valuation
46
Growth
65
Profitability
63
Financial Health
85
Cash Flow
70
Valuation
P/E Ratio 38.1×
P/B Ratio 2.89×
PEG Ratio 1.96
Dividend Yield 0.67%
52W High $242.80
52W Low $160.93
Quality & Growth
ROE 687.9%
ROA 433.0%
Gross Margin 5851.4%
Operating Margin 2042.1%
Revenue Growth YoY
Debt / Equity 0.51
AI Fundamental Assessment
P/E ratio of 38.1 (rich relative to a 15-40x range); Price-to-book of 2.9x; PEG ratio of 2.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 6.9%; Return on assets of 4.3%; Net margin of 15.9%; Gross margin of 58.5%; Current ratio of 1.65 (healthy short-term liquidity); Debt-to-equity of 0.51; Free cash flow per share is positive (7.75); Most recent quarter beat estimates by 4.7%; 5 consecutive earnings beats; EPS growth roughly steady (-7.6% -> -5.8% QoQ); Average YoY EPS growth of 7.8%; Analyst estimates falling over recent quarters
Get the Full DHR Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime